The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
about
Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancyAdvances in systemic therapy for advanced pancreatobiliary malignanciesIntrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapiesThe oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.Results of a phase I-II study on intraductal confocal microscopy (IDCM) in patients with common bile duct (CBD) stenosis.Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes.Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study.Markers of bile duct tumorsOver-expression of nerve growth factor-β in human cholangiocarcinoma QBC939 cells promote tumor progression.CD24 expression is an independent prognostic marker in cholangiocarcinoma.Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor.Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinomaA perspective on molecular therapy in cholangiocarcinoma: present status and future directions.Genetics of biliary tract cancers and emerging targeted therapies.Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities.Targeted therapy for biliary tract cancers.Biomarkers in bile-complementing advanced endoscopic imaging in the diagnosis of indeterminate biliary strictures.Emerging molecular targets and therapy for cholangiocarcinoma.Dickkopf-1 is a novel prognostic biomarker for laryngeal squamous cell carcinoma.High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy.Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.Targeted medical therapy of biliary tract cancer: recent advances and future perspectives.Cholangiocarcinoma: estrogen-induced autocrine effects of VEGF on cell proliferation.A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma.Vascular endothelial growth factor levels in bile distinguishes pancreatic cancer from other etiologies of biliary stricture: a pilot study.Quantitative analysis of VEGF-C mRNA of extrahepatic cholangiocarcinoma with real-time PCR using samples obtained during endoscopic retrograde cholangiopancreatography.
P2860
Q26767120-C2F4F456-C101-4A96-807A-F09586E8BF6EQ26822703-F19F5823-CE73-4615-87B2-8BB2E835D5AFQ27002547-3B279E19-461C-40F6-850A-3260F9662FA0Q33441341-CCFFF3AB-0D29-42DB-A67A-A769837FB6BCQ33851876-A6F0A9F0-B9F9-40C1-8721-0DAB889502BBQ33909909-49FE8DC5-1624-4C58-9031-34C4A0745B42Q34048813-9F2924E1-2A4D-457E-8557-A7265A853F87Q34628852-1728497E-82F7-44E8-A300-129680041506Q34700856-A90864DE-81CA-43F8-9454-76BF924191E0Q35751592-646F2954-18F3-4D72-8752-C00AAFD4C574Q36962011-C4ABBF63-F0D2-4501-8221-DF73DC2BF11EQ37060540-0C9E5600-FF0C-4CC9-8C96-DB9B31C3151BQ37351498-40893CFF-4407-4F2A-A1F7-9BDA23CCA6CBQ37719383-C2D81272-69DE-4FA7-AFB9-851F5B2515CEQ37765099-B4CDA347-0328-41FF-9DA9-C25C14C04800Q37833005-81D69AE3-DB81-43E4-BAF2-4CE8F7577066Q37982650-74430E1B-5777-4D47-886A-58E197C4DE2CQ38434946-3AEDAA1F-9CF1-48D5-ABCF-F94A33B644B1Q38642455-0D794846-6BAE-4022-A8E8-034F2F99594CQ38994435-B5A66D67-1776-45F9-89F9-35807F4FCF28Q39248557-AF457FBC-92FE-47BC-9357-4F17EAF6BC34Q39345895-5FC75BCB-D49B-4F1A-BD89-A9CD0352557AQ39995898-9C2250E9-8DB0-4E9F-96C8-EC88A5C08EB9Q42272472-06F48FD6-FD7D-4006-85C9-62067C2C4DEAQ42635172-11CF4943-A33C-4B07-82C4-50C857C3148FQ43164490-560D9999-1F5A-451F-9A7B-DDB38477F2FEQ47861428-0E58B767-98FD-481B-A616-15773F697E9BQ50857297-9DEE4A19-1BF2-49CE-A631-85E44D0CA6DFQ50950470-092C42A7-BF0D-4573-AF05-B2F1F9CB359C
P2860
The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The clinicopathologic signific ...... trahepatic cholangiocarcinoma.
@en
The clinicopathologic signific ...... trahepatic cholangiocarcinoma.
@nl
type
label
The clinicopathologic signific ...... trahepatic cholangiocarcinoma.
@en
The clinicopathologic signific ...... trahepatic cholangiocarcinoma.
@nl
prefLabel
The clinicopathologic signific ...... trahepatic cholangiocarcinoma.
@en
The clinicopathologic signific ...... trahepatic cholangiocarcinoma.
@nl
P2093
P1476
The clinicopathologic signific ...... trahepatic cholangiocarcinoma.
@en
P2093
Byung Kyu Park
Jae Bock Chung
Jeong Youp Park
Kyung Hwa Park
Seung Woo Park
Seungmin Bang
Si Young Song
Yong-Han Paik
Young Nyun Park
P304
P356
10.1097/01.COC.0000204402.29830.08
P577
2006-04-01T00:00:00Z